MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Sector
Medical Device Sector
Trauma, Blood, Wound Healing & Emergency Sector
*Driving Forces: Medical Devices & Technology (Trends)
2014: The top three players in Point of Care diagnostics are Alere, Danaher (NYSE: DHR), and Roche
Danaher Corporation (NYSE:DHR)
Organization & Developments: Danaher
Parents
Danaher Corporation (NYSE:DHR)
Children
*Addressing worldwide markets from a strong base in Europe, Danaher’s medical technology businesses illustrate the benefits of global thinking and customer-focused product innovation.
*Danaher: Business Areas
*Danaher: Organizations
*Danaher: Products
*Danaher’s associates work within a global family of more than 20 operating companies focused on biotech and life sciences, as well as diagnostics, water quality, and product identificatio
*Danaher’s newest platform encompasses technologies that are contributing to a revolution in dentistry and providing frontline support for critical care in hospitals
*In hospitals, blood gas analyzers facilitate potentially lifesaving decisions in diagnosis and treatment.
*Integrated DNA Technologies, Inc. (IDT)
*The dental products range from digital panoramic imaging systems to breakthrough devices that replace traditional “drill and fill” approaches with painless, proactive solutions.
2014: Danaher (DHR) Can't Make A Deal Even With $12B Handy _ Danahers Takeover Minded Owner Now Cant Make A
2016: Why Danaher Plans to Split Up
2020: Danaher: Expect Continued Strong Shareholder Returns With GE Biopharma_seekingalpha.com
2022: Danaher: Best Healthcare Company In Inflationary Environment_seekingalpha.com
2022: Danaher: Best Healthcare Company In Inflationary Environment_seekingalpha.com
2023: My Top 2024 Stock Pick: Danaher_ seekingalpha.com
2024: Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
2024: Danaher to Benefit From Business Strength Amid Headwinds
2024: Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
2024: Danaher: All In On Life Sciences, And Market Update
2024: Danaher: Lofty Price, Bright Future
2024: Danaher's SWOT analysis: stock outlook amid mixed q4 guidance and china concerns
2025: Danaher Corporation: Question Mark Behind The Moat And Probably Overvalued
2025: Danaher: A Wide-Moat Gem I Cannot Buy Enough Of_ seekingalpha.com
2025: Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside
2025: Danaher: Self-Inflicted Pessimism?_ seekingalpha.com
2025: Danaher: Transition Year Recap
2025: From Promise to Practice: Danaher Gathers Visionaries to Discuss AI-Driven R&D
2026: Danaher Is Getting Better, But The Stock Still Isn't Cheap (NYSE:DHR)
Aldevron
Integrated DNA Technologies
Jumps
*Key People: Danaher
Finance & Acquisitions: Danaher